Fischer Medical Ventures Financial Results
- Market cap
- ₹2,136 crore
- P/E
- 68.6
- P/B
- 5.56
- ROE
- 8.6%
- Dividend yield
- 0.15%
For the year ended Mar 2023, Fischer Medical Ventures reported revenue of ₹0 crore and net profit of ₹0 crore, against ₹21 crore and ₹2 crore a year earlier.
Fischer Medical Ventures annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Revenue | 0 | 21 | 111 | 309 | 367 |
| Expenses | 0 | 19 | 106 | 257 | 308 |
| Operating profit | 0 | 2 | 5 | 52 | 59 |
| Operating margin % | 9% | 9% | 4% | 17% | 16% |
| Other income | 0 | 1 | 0 | 3 | -3 |
| Interest | 0 | 0 | 0 | 5 | 8 |
| Depreciation | 0 | 0 | 2 | 3 | 4 |
| Profit before tax | 0 | 2 | 3 | 47 | 44 |
| Tax % | -2,708% | 13% | 37% | 33% | 32% |
| Net profit | 0 | 2 | 1 | 31 | 30 |
| EPS (₹) | -2.12 | 0.34 | 0.23 | 0.49 | 0.48 |
| Dividend payout % | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Fischer Medical Ventures financial results — frequently asked questions
What is Fischer Medical Ventures' annual revenue and net profit?
For the financial year ended Mar 2023, Fischer Medical Ventures' revenue was ₹0 crore and net profit ₹0 crore; net profit fell 100.00% from ₹2 crore in Mar 2024.
What is the EPS of Fischer Medical Ventures?
Annual EPS for Mar 2023 was -₹2.12.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Fischer Medical Ventures With ATS
Track FISCHER live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.